Saito Y - Search Results

1

Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.

Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Kojima S, et al. Among authors: saito y. Rheumatology (Oxford). 2022 May 30;61(6):2346-2359. doi: 10.1093/rheumatology/keab739. Rheumatology (Oxford). 2022. PMID: 34605897 Clinical Trial.

2

Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes.

Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Yamamuro M, Harada M, Saito Y, Nakao K, Kurihara H, Yasue H, Ogawa H. Ito T, et al. Among authors: saito y. Circulation. 2003 Feb 18;107(6):807-10. doi: 10.1161/01.cir.0000057794.29667.08. Circulation. 2003. PMID: 12591748

3

Synergistic interaction of T-786-->C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm.

Nakayama M, Yoshimura M, Sakamoto T, Shimasaki Y, Nakamura S, Ito T, Abe K, Yamamuro M, Miyamoto Y, Saito Y, Nakao K, Yasue H, Ogawa H. Nakayama M, et al. Among authors: saito y. Pharmacogenetics. 2003 Nov;13(11):683-8. doi: 10.1097/00008571-200311000-00004. Pharmacogenetics. 2003. PMID: 14583681

4

Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.

Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, Nakamura S, Abe K, Yamamuro M, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H. Suzuki S, et al. Among authors: saito y. Circulation. 2004 Sep 14;110(11):1387-91. doi: 10.1161/01.CIR.0000141295.60857.30. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353502

5

Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart.

Nakamura S, Yoshimura M, Nakayama M, Ito T, Mizuno Y, Harada E, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H. Nakamura S, et al. Among authors: saito y. Circulation. 2004 Sep 28;110(13):1787-93. doi: 10.1161/01.CIR.0000143072.36782.51. Epub 2004 Sep 13. Circulation. 2004. PMID: 15364798

6

Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism.

Abe K, Nakayama M, Yoshimura M, Nakamura S, Ito T, Yamamuro M, Sakamoto T, Miyamoto Y, Yoshimasa Y, Saito Y, Nakao K, Yasue H, Ogawa H. Abe K, et al. Among authors: saito y. Pharmacogenet Genomics. 2005 May;15(5):329-36. doi: 10.1097/01213011-200505000-00008. Pharmacogenet Genomics. 2005. PMID: 15864134

7

Direct effects of aldosterone on cardiomyocytes in the presence of normal and elevated extracellular sodium.

Yamamuro M, Yoshimura M, Nakayama M, Abe K, Shono M, Suzuki S, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H. Yamamuro M, et al. Among authors: saito y. Endocrinology. 2006 Mar;147(3):1314-21. doi: 10.1210/en.2005-1244. Epub 2005 Dec 22. Endocrinology. 2006. PMID: 16373419

8

A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine.

Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, Suzuki S, Nishijima T, Miyamoto Y, Saito Y, Nakao K, Yasue H, Ogawa H. Nakayama M, et al. Among authors: saito y. Pharmacogenet Genomics. 2006 May;16(5):339-45. doi: 10.1097/01.fpc.0000199499.08725.d5. Pharmacogenet Genomics. 2006. PMID: 16609365

9

The effects of long-term smoking on endothelial nitric oxide synthase mRNA expression in human platelets as detected with real-time quantitative RT-PCR.

Shimasaki Y, Saito Y, Yoshimura M, Kamitani S, Miyamoto Y, Masuda I, Nakayama M, Mizuno Y, Ogawa H, Yasue H, Nakao K. Shimasaki Y, et al. Among authors: saito y. Clin Appl Thromb Hemost. 2007 Jan;13(1):43-51. doi: 10.1177/1076029606296402. Clin Appl Thromb Hemost. 2007. PMID: 17164495 Free article.

10

Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure.

Shono M, Yoshimura M, Nakayama M, Yamamuro M, Abe K, Suzuki S, Mizuno Y, Sugiyama S, Saito Y, Nakao K, Yasue H, Ogawa H. Shono M, et al. Among authors: saito y. Circ J. 2007 Jul;71(7):1040-6. doi: 10.1253/circj.71.1040. Circ J. 2007. PMID: 17587708 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,684 results

Search Page

Filters